A Phase II study of FZ002-037 in diabetic peripheral neuropathy.
Latest Information Update: 22 Jan 2025
Price :
$35 *
At a glance
- Drugs FZ 002 (Primary)
- Indications Diabetic neuropathies; Peripheral neuropathies
- Focus Therapeutic Use
- 22 Jan 2025 New trial record
- 17 Jan 2025 According to the Guangzhou Fermion Technology Media Release, this trial in diabetic peripheral neuropathy set to begin soon.